Lv1
20 积分 2025-10-17 加入
Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study
3小时前
待确认
mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study
3小时前
已完结
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
3个月前
已完结
皖公网安备34019202002308
